Vimarsana
Biggest News Aggregation in the World

Visual Analog Score News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Visual Analog Score. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Visual Analog Score Today - Breaking & Trending Today

Lemon verbena extract boosts sleep quality - Vimarsana News

Lemon verbena extract boosts sleep quality

Researchers explore the utility of lemon verbena in improving the sleep of individuals with poor sleep.

Nonsevere COVID-19 Disease Common in Patients With Chronic HBV Infection - Vimarsana News

Nonsevere COVID-19 Disease Common in Patients With Chronic HBV Infection

Patients with chronic HBV infection receiving TDF or ETV mainly experienced nonsevere disease when infected COVID-19.

Study Highlights Uneven Symptom Burden in Patients With Uncontrolled vs Controlled Severe Asthma - Vimarsana News

Study Highlights Uneven Symptom Burden in Patients With Uncontrolled vs Controlled Severe Asthma

An analysis found that patients with uncontrolled severe asthma have a higher symptom burden compared with those whose severe asthma is controlled, highlighting the need for more innovative treatment options to improve asthma control.

Source: ajmc.com
Joint ingredient shown to work in only five days - Vimarsana News

Joint ingredient shown to work in only five days

The revolution in joint-health supplements continues with an innovative, fast-acting frankincense ingredient.

Mesoblast Phase 3 Trial Shows That a Single Injection of Rexlemestrocel-L + Hyaluronic Acid Carrier Results in at Least Two Years of Pain Reduction With Opioid Sparing Activity in Patients With Chronic Low Back Pain Due to Degenerative Disc Disease - Vimarsana News

Mesoblast Phase 3 Trial Shows That a Single Injection of Rexlemestrocel-L + Hyaluronic Acid Carrier Results in at Least Two Years of Pain Reduction With Opioid Sparing Activity in Patients With Chronic Low Back Pain Due to Degenerative Disc Disease

Mesoblast Phase 3 Trial Shows That a Single Injection of Rexlemestrocel-L + Hyaluronic Acid Carrier Results in at Least Two Years of Pain Reduction With Opioid Sparing Activity in Patients With Chronic Low Back Pain Due to Degenerative Disc Disease February 10, 2021 18:42 ET | Source: Mesoblast Limited Mesoblast Limited Melbourne, AUSTRALIA NEW YORK, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced results from the Phase 3 randomi...